Tatiana Marcal
San Francisco Clinical Research CenterSan Francisco
329930 RESULTS
San Francisco Clinical Research CenterSan Francisco
RESEARCH NEWS 2014-04-01 Research News On March 31, the Australian company Prana Biotechnology announced negative top-line results of its only Phase 2 study of the anti-amyloid drug PBT2. Called IMAGINE, the trial had enrolled 42 people with prodromal or mild Alzheimer’s disease
Stanford University
PAPER Hegde ML, Anitha S, Jagannatha KS
PAPER Bliwise DL, Hughes M, McMahon PM, Kutner N
University of São PauloBrazil
Tsai Lab
PAPER Koh JT, Lee ZH, Ahn KY, Kim JK, Bae CS, Kim HH, Kee HJ, Kim KK
Abbvie
Akershus University HospitalNorway
PAPER Ross AJ, Sachdev PS, Wen W, Brodaty H, Joscelyne A, Lorentz LM
University of OxfordUnited Kingdom
University of WashingtonSeattle, United States
Selonterra LLC
No filters selected